On Invalid Date, Allarity Therapeutics (NASDAQ: ALLR) reported Q4 2022 earnings per share (EPS) of -$8.05, up 90.76% year over year. Total Allarity Therapeutics earnings for the quarter were -$3.10 million. In the same quarter last year, Allarity Therapeutics's earnings per share (EPS) was -$87.15.
As of Q2 2023, Allarity Therapeutics's earnings has grown year over year. Allarity Therapeutics's earnings in the past year totalled -$21.05 million.
What is ALLR's earnings date?
Allarity Therapeutics's earnings date is Invalid Date. Add ALLR to your watchlist to be reminded of ALLR's next earnings announcement.
What was ALLR's revenue last quarter?
On Invalid Date, Allarity Therapeutics (NASDAQ: ALLR) reported Q4 2022 revenue of $0.00 up N/A year over year. In the same quarter last year, Allarity Therapeutics's revenue was $0.00.
What was ALLR's revenue growth in the past year?
As of Q2 2023, Allarity Therapeutics's revenue has grown null year over year. Allarity Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.